Potentiation of trichothecene-induced leukocyte cytotoxicity and apoptosis by TNF-α and Fas activation

Chemico-Biological Interactions

Volumn 146, Issue 2, 2003, Pages 105-119

  Uzarski, Rebecca L ^a   Islam, Zahidul ^a   Pestka, James J ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Dexamethasone; Immunotoxicity; LPS; Mycotoxin; Prostaglandin; Tas; TNF

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 3; CASPASE 3 INHIBITOR; DEXAMETHASONE; FAS LIGAND; IMMUNOGLOBULIN M ANTIBODY; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; RPMI 1640; TRICHOTHECENE; TRICHOTHECENE DEOXYNIVALENOL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; FEMALE; IMMUNE RESPONSE; LEUKOCYTE; LEUKOCYTE CULTURE; MOUSE; NONHUMAN; PEYER PATCH; SPLEEN; THYMUS;

BACTERIA (MICROORGANISMS); MURINAE;

EID: 0142249262     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(03)00088-7     Document Type: Article

References (85)

1. Wolf-Hall C.E., Hanna M.A., Bullerman L.B. Stability of deoxynivalenol in heat-treated foods. J. Fd. Protec. 62:1999;962-964.
2. Abouzied M.M., Azcona J.I., Braselton W.E., Pestka J.J. Immunochemical assessment of mycotoxins in grain foods: evidence for vomitoxin (deoxynivalenol) contamination. Appl. Environ. Microbiol. 57:(1991):1989;672-677.
3. Bondy G.S., Pestka J.J. Immunomodulation by fungal toxins. J. Toxicol. Environ. Health B Crit. Rev. 3:2000;109-143.
4. Y. Ueno, General toxicology, In: Y. Ueno (Ed.), Trichothecenes: Chemical, Biological, and Toxicological Aspects, New York, 1983. Elsevier pp. 135-146.
5. Islam Z., Nagase M., Yoshizawa T., Yamauchi K., Sakato N. T-2 toxin induces thymic apoptosis in vivo in mice. Toxicol. Appl. Pharmacol. 148:1998;205-214.
6. Shinozuka J., Guanmin L., Uetsuka K., Nakayama H., Doi K. Process of the development of T-2 toxin-induced apoptosis in the lymphoid organs of mice. Exp. Anim. 46:1997;117-126.
7. Bamburg J.R. The biological activities and detection of naturally occurring 12,13-epoxy-delta9-trichothecenes. Clin. Toxicol. 5:1972;495-515.
8. Li F.Q., Luo X.Y., Yoshizawa T. Mycotoxins (trichothecenes, zearalenone and fumonisins) in cereals associated with human red-mold intoxications stored since and 1991 in China. Nat. Toxins. 7:(1999):1989;93-97.
9. Albers R., van der P.A., Bol M., Seinen W., Pieters R. Stress proteins (HSP) and chemical-induced autoimmunity. Toxicol. Appl. Pharmacol. 140:1996;70-76.
10. Pruett S.B., Ensley D.K., Crittenden P.L. The role of chemical-induced stress responses in immunosuppression: a review of quantitative associations and cause-effect relationships between chemical-induced stress responses and immunosuppression. J. Toxicol. Environ. Health. 39:1993;163-192.
11. Luster M.I., Simeonova P.P., Gallucci R.M., Bruccoleri A., Blazka M.E., Yucesoy B., Matheson J.M. The role of tumor necrosis factor alpha in chemical-induced hepatotoxicity. Ann. NY Acad. Sci. 919:2000;214-220.
12. Emmendoerffer A., Hecht M., Boeker T., Mueller M., Heinrich U. Role of inflammation in chemical-induced lung cancer. Toxicol. Letts. 112-113:2000;185-191.
13. Roth R.A., Harkema J.R., Pestka J.J., Ganey P.E. Is exposure to bacterial endotoxin a determinant of susceptibility to intoxication from xenobiotic agents? Toxicol. App. Pharmacol. 147:1997;300-311.
14. Tai J.H., Pestka J.J. Synergistic interaction between the trichothecene T-2 toxin and Salmonella typhimurium lipopolysaccharide in C3H/HeN and C3H/HeJ mice. Toxicol. Letts. 191:(44):1988;200.
15. Zhou H.R., Harkema J.R., Hotchkiss J.A., Yan D., Roth R.A., Pestka J.J. Lipopolysaccharide and the trichothecene vomitoxin (deoxynivalenol) synergistically induce apoptosis in murine lymphoid organs. Toxicol. Sci. 53:2000;253-263.
16. Zhou H.R., Harkema J.R., Yan D., Pestka J.J. Amplified proinflammatory cytokine expression and toxicity in mice coexposed to lipopolysaccharide and the trichothecene vomitoxin (deoxynivalenol). J. Toxicol. Environ. Health. 57:1999;115-136.
17. Stiles G.L. Photoaffinity cross-linked A1 adenosine receptor-binding subunits. Homologous glycoprotein expression by different tissues. J. Biol. Chem. 261:1986;10839-10843.
18. Marin M.L., Murtha J., Dong W., Pestka J.J. Effects of mycotoxins on cytokine production and proliferation in EL-4 thymoma cells. J. Toxicol. Environ. Health. 1996;379-396.
19. Duke R.C., Cohen J.J. Morphological, biochemical, and flow cytometric assays of apoptosis. Curr. Protocols Immunol. 1995;3.17.13-3.17.33.
20. L.J. Casarrett, M.O. Amdur, C.D. Klaasen, Casarett and Doull's Toxicology: The Basic Science of Poisons. McGraw-Hill, Health Professions Division, New York.
21. Yang G.H., Jarvis B.B., Chung Y.J., Pestka J.J. Apoptosis induction by the satratoxins and other trichothecene mycotoxins: relationship to ERK, p38 MAPK, and SAPK/JNK activation. Toxicol. Appl. Pharmacol. 164:2000;149-160.
22. Okumura H., Yoshino N., Ihara T., Sugamata M., Ueno Y. Induction of apoptotic cell death by trichothecenes. Mycotoxins. 50:2000;41-44.
23. Shifrin V.I., Anderson P. Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J. Biol. Chem. 274:1999;13985-13992.
24. Hanelt M., Gareis M., Kollarczik B. Cytotoxicity of mycotoxins evaluated by the MTT-cell culture assay. Mycopathologia. 128:1994;167-174.
25. Anderson D.W., Black R.M., Lee C.G., Pottage C., Rickard R.L., Sandford M.S., Webber T.D., Williams N.E. Structure-activity studies of trichothecenes: cytotoxicity of analogues and reaction products derived from T-2 toxin and neosolaniol. J. Med. Chem. 32:1989;555-562.
26. Yike I., Allan T., Sorenson W.G., Dearborn D.G. Highly sensitive protein translation assay for trichothecene toxicity in airborne particulates: comparison with cytotoxicity assays. Appl. Environ. Microbiol. 65:1999;88-94.
27. Oberholzer C., Oberholzer A., Clare-Salzler M., Moldawer L.L. Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J. 15:2001;879-892.
28. Ayala A., Herdon C.D., Lehman D.L., Ayala C.A., Chaudry I.H. Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood. 87:1996;4261-4275.
29. Zhang Y.H., Takahashi K., Jiang G.Z., Kawai M., Fukada M., Yokochi T. In vivo induction of apoptosis (programmed cell death) in mouse thymus by administration of lipopolysaccharide. Infect. Immun. 61:1993;5044-5048.
30. Zhang X.M., Morikawa A., Takahashi K., Jiang G.Z., Kato Y., Sugiyama T., Kawai M., Fukada M., Yokochi T. Localization of apoptosis (programmed cell death) in mice by administration of lipopolysaccharide. Microbiol. Immunol. 38:1994;669-671.
31. Tilley S.L., Coffman T.M., Koller B.H. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108:2001;15-23.
32. Brown D.M., Warner G.L., Ales-Martinez J.E., Scott D.W., Phipps R.P. Prostaglandin E2 induces apoptosis in immature normal and malignant B lymphocytes. Clin. Immunol. Immunopathol. 63:1992;221-229.
33. Pica F., Franzese O., Onofrio C.D., Bonmassar E., Favalli C., Garaci E. Prostaglandin E2 induces apoptosis in resting immature and mature human lymphocytes: a c-Myc-dependent and Bcl-2-independent associated pathway. J. Pharmacol. Exp. Therapeutics. 277:1996;1793-1800.
34. Mastino A., Piacentini M., Grelli S., Favalli C., Autuori F., Tentori L., Oliverio S., Garaci E. Induction of apoptosis in thymocytes by prostaglandin E2 in vivo. Dev. Immunol. 2:1992;263-271.
35. Hasbold J., Klaus G.G. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur. J. Immunol. 20:1990;1685-1690.
36. Joseph L.F., Ezhevsky S., Scott D.W. Lymphoma models for B-cell activation and tolerance: anti-immunoglobulin M treatment induces growth arrest by preventing the formation of an active kinase complex which phosphorylates retinoblastoma gene product in G1. Cell Growth Differ. 6:1995;51-57.
37. Gottschalk A.R., Quintans J. Apoptosis in B lymphocytes: the WEHI-231 perspective. Immunol. Cell Biol. 73:1995;8-16.
38. Modigliani Y., Demengeot J., Vasconcellos R., Andersson J., Coutinho A., Grandien A. Differential sensitivity of B lymphocyte populations to IgM receptor ligation is determined by local factors. Int. Immunol. 9:1997;755-762.
39. Cabrera R., Korte S.M., Lentjes E.G., Romijn F., Schonbaum E., De Nicola A., De Kloet E.R. The amount of free corticosterone is increased during lipopolysaccharide-induced fever. Life Sci. 66:2000;553-562.
40. Bailly-Maitre B., de Sousa G., Boulukos K., Gugenheim J., Rahmani R. Dexamethasone inhibits spontaneous apoptosis in primary cultures of human and rat hepatocytes via Bcl-2 and Bcl-xL induction. Cell Death Differ. 8:2001;279-288.
41. Krishna G., Urda G., Tefera W., Lalwani N.D., Theiss J. Simultaneous evaluation of dexamethasone-induced apoptosis and micronuclei in rat primary spleen cell cultures. Mutat. Res. 332:1995;1-8.
42. Andreau K., Lemaire C., Souvannavong V., Adam A. Induction of apoptosis by dexamethasone in the B cell lineage. Immunopharmacology. 40:1998;67-76.
43. Gruber J., Sgonc R., Hu Y.H., Beug H., Wick G. Thymocyte apoptosis induced by elevated endogenous corticosterone levels. Eur. J. Immunol. 24:1994;1115-1121.
44. Pestka J.J., Yan D., King L.E. Flow cytometric analysis of the effects of in vitro exposure to vomitoxin (deoxynivalenol) on apoptosis in murine T, B and IgA+ cells. Fd. Chem. Toxicol. 32:1994;1125-1136.
45. Ray A., Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA. 91:1994;752-756.
46. Scheinman R.I., Cogswell P.C., Lofquist A.K., Baldwin A.S. Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 270:1995;283-286.
47. Donjerkovic D., Mueller C.M., Scott D.W. Steroid- and retinoid-mediated growth arrest and apoptosis in WEHI-231 cells: role of NF-kappaB, c-Myc and CKI p27(Kip1). Eur. J. Immunol. 30:2000;1154-1161.
48. Ouyang Y.L., Li S., Pestka J.J. Effects of vomitoxin (deoxynivalenol) on transcription factor NF-kappa B/Rel binding activity in murine EL-4 thymoma and primary CD4+ T cells. Toxicol. Appl. Pharmacol. 140:1996;328-336.
49. Wu M., Lee H., Bellas R.E., Schauer S.L., Arsura M., Katz D., FitzGerald M.J., Rothstein T.L., Sherr D.H., Sonenshein G.E. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J. 15:1996;4682-4690.
50. R.E. Voll, S. Ghosh. Role of NF-KB on T-lymphocyte development, Cold. Spring Harb. Quant Biol. 64 (1999) 485-490.
51. Fricke R.F., Jorge J. Beneficial effect of dexamethasone in decreasing the lethality of acute T-2 toxicosis. Gen. Pharmacol. 22:1991;1087-1091.
52. Harvey P.W., Healing G., Rees S.J., Everett D.J., Cockburn A. Glucocorticosteroid interactions with natural toxins: a mini review. Nat. Toxins. 2:1994;341-346.
53. Ayala A., Xin X.Y., Ayala C.A., Sonefeld D.E., Karr S.M., Evans T.A., Chaudry I.H. Increased mucosal B-lymphocyte apoptosis during polymicrobial sepsis is a Fas ligand but not an endotoxin-mediated process. Blood. 91:1998;1362-1372.
54. Kitamura Y., Hashimoto S., Mizuta N., Kobayashi A., Kooguchi K., Fujiwara I., Nakajima H. Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. Am. J. Respir. Crit. Care Med. 163:2001;762-769.
55. Nilsson N., Ingvarsson S., Borrebaeck C.A. Immature B cells in bone marrow express Fas/FasL. Scand. J. Immunol. 51:2000;279-284.
56. Nishimura Y., Hirabayashi Y., Matsuzaki Y., Musette P., Ishii A., Nakauchi H., Inoue T., Yonehara S. In vivo analysis of Fas antigen-mediated apoptosis: effects of agonistic anti-mouse Fas mAb on thymus, spleen and liver. Int. Immunol. 9:1997;307-316.
57. Kakinuma C., Takagaki K., Yatomi T., Nakamura N., Nagata S., Uemura A., Shibutani Y. Acute toxicity of an anti-Fas antibody in mice. Toxicol. Pathol. 27:1999;412-420.
58. Watanabe D., Suda T., Nagata S. Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells. Int. Immunol. 7:1995;1949-1956.
59. Quirk S.M., Porter D.A., Huber S.C., Cowan R.G. Potentiation of Fas-mediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide. Endocrinology. 139:1998;4860-4869.
60. Kimura K., Yamamoto M. Rapid induction of Fas antigen mRNA expression in vivo by cycloheximide. Cell Biochem. Funct. 15:1997;81-86.
61. Tang D., Lahti J.M., Grenet J., Kidd V.J. Cycloheximide-induced T-cell death is mediated by a Fas-associated death domain-dependent mechanism. J. Biol. Chem. 274:1999;7245-7252.
62. Baud V., Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11:2001;372-377.
63. Siegmund D., Hausser A., Peters N., Scheurich P., Wajant H. Tumor necrosis factor (TNF) and phorbol ester induce TNF-related apoptosis-inducing ligand (TRAIL) under critical involvement of NF-kappa B essential modulator (NEMO)/IKKgamma. J. Biol. Chem. 276:2001;43708-43712.
64. Baetu T.M., Kwon H., Sharma S., Grandvaux N., Hiscott J. Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression. J. Immunol. 167:2001;3164-3173.
65. Hettmann T., DiDonato J., Karin M., Leiden J.M. An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis. J. Exp. Med. 189:1999;145-158.
66. Bessho R., Matsubara K., Kubota M., Kuwakado K., Hirota H., Wakazono Y., Lin Y.W., Okuda A., Kawai M., Nishikomori R. Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem. Pharmacol. 48:1994;1883-1889.
67. Senftleben U., Li Z.W., Baud V., Karin M. IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis. Immunity. 14:2001;217-230.
68. Choi K.B., Wong F., Harlan J.M., Chaudhary P.M., Hood L., Karsan A. Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway. J. Biol. Chem. 273:1998;20185-20188.
69. Talley A.K., Dewhurst S., Perry S.W., Dollard S.C., Gummuluru S., Fine S.M., New D., Epstein L.G., Gendelman H.E., Gelbard H.A. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol. Cell. Biol. 15:1995;2359-2366.
70. Cossarizza A., Franceschi C., Monti D., Salvioli S., Bellesia E., Rivabene R., Biondo L., Rainaldi G., Tinari A., Malorni W. Protective effect of N-acetylcysteine in tumor necrosis factor-alpha- induced apoptosis in U937 cells: the role of mitochondria. Exp. Cell Res. 220:1995;232-240.
71. Chiba T., Takahashi S., Sato N., Ishii S., Kikuchi K. Fas-mediated apoptosis is modulated by intracellular glutathione in human T cells. Eur. J. Immunol. 26:1996;1164-1169.
72. Shrivastava A., Aggarwal B.B. Antioxidants differentially regulate activation of nuclear factor- kappa B, activator protein-1, c-jun amino-terminal kinases, and apoptosis induced by tumor necrosis factor: evidence that JNK and NF-kappa B activation are not linked to apoptosis. Antioxid. Redox. Signal. 1:1999;181-191.
73. Giardina C., Boulares H., Inan M.S. NSAIDs and butyrate sensitize a human colorectal cancer cell line to TNF-alpha and Fas ligation: the role of reactive oxygen species. Biochimica et Biophysica Acta. 1448:1999;425-438.
74. Hampton M.B., Vanags D.M., Porn-Ares M.I., Orrenius S. Involvement of extracellular calcium in phosphatidylserine exposure during apoptosis. FEBS Letts. 399:1996;277-282.
75. Denecker G., Vandenabeele P., Grooten J., Penning L.C., Declercq W., Beyaert R., Buurman W.A., Fiers W. Differential role of calcium in tumour necrosis factor-mediated apoptosis and secretion of granulocyte-macrophage colony-stimulating factor in a T cell hybridoma. Cytokine. 9:1997;631-638.
76. Hueber A.O., Zornig M., Bernard A.M., Chautan M., Evan G. A dominant negative Fas-associated death domain protein mutant inhibits proliferation and leads to impaired calcium mobilization in both T-cells and fibroblasts. J. Biol. Chem. 275:2000;10453-10462.
77. Ko S., Kwok T.T., Fung K.P., Choy Y.M., Lee C.Y., Kong S.K. Slow rise of Ca2+ and slow release of reactive oxygen species are two cross-talked events important in tumour necrosis factor- alpha-mediated apoptosis. Free Radical Res. 33:2000;295-304.
78. Roulston A., Reinhard C., Amiri P., Williams L.T. Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J. Biol. Chem. 273:1998;10232-10239.
79. Sugawara T., Moriguchi T., Nishida E., Takahama T. Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes. Immunity. 9:1998;565-574.
80. Herr I., Wilhelm D., Meyer E., Jeremias I., Angel P., Debatin K.M. JNK/SAPK activity contributes to TRAIL-induced apoptosis. Cell Death Differ. 6:1999;130-135.
81. Belka C., Schmid B., Marini P., Durand E., Rudner J., Faltin H., Bamberg M., Schulze-Osthoff K., Budach W. Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL. Oncogene. 20:2001;2190-2196.
82. Aggarwal S., Gollapudi S., Yel L., Gupta A.S., Gupta S. TNF-alpha-induced apoptosis in neonatal lymphocytes: TNFRp55 expression and downstream pathways of apoptosis. Genes Immun. 1:2000;271-279.
83. MacFarlane M., Cohen G.M., Dickens M. JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation. Biochem. J. 348:(Pt 1):2000;93-101.
84. Cohen G.M. Caspases: the executioners of apoptosis. Biochem. J. 326:(Pt 1):1997;1-16.
85. Islam Z., Moon Y.S., Zhou H.-R., King L.E., Fraker P.J., Pestka J.J. Endotoxin potentiation of trichothecene-induced lymphocyte apoptosis is mediated by up-regulation of glucocorticoids. Toxicol. Appl. Pharmacol. 180:2002;43-55.